Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...
02 Jun, 2026, 03.30 PM IST
Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
20 May, 2026, 12.05 PM IST
Semaglutide race: Torrent grabs 38% market shareOver a dozen Indian companies have launched generic versions of the GLP1 drug used for diabetes and weight management since the expiry of N...
08 May, 2026, 08.54 AM IST
Small & midcaps rally! Wockhardt, Coforge, other stocks surge up to 14%. Do you own any?Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...
06 May, 2026, 11.56 AM IST
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
29 Apr, 2026, 02.22 PM IST
Stocks in news: Infosys, Trent, Jio Financial, Hindustan Copper, Adani EnergyMarkets experienced a corrective session, with Nifty expected to consolidate but maintain a positive bias. Key stocks like Infosys, Trent, ...
23 Apr, 2026, 06.33 AM IST
Alkem Labs CEO Vikas Gupta may exit companyAlkem Labs, a leading Indian drug maker, is set for a top management change. Vikas Gupta, the CEO for nearly three years, is expected to de...
23 Apr, 2026, 06.20 AM IST
Alkem Laboratories launches semaglutide in India at Rs 450 per week, eyes booming weight-loss marketAlkem Laboratories has launched a new semaglutide injection in India. This drug targets the growing diabetes and weight loss market. It is ...
21 Mar, 2026, 05.07 PM IST
Obesity bet may drive focus on chronic segment: Alkem LabsAlkem Labs anticipates its upcoming semaglutide launch will drive a strategic shift from acute treatments to chronic care, including diabet...
21 Mar, 2026, 01.07 AM IST
Add Alkem Laboratories, target price Rs 5,700: HDFC SecuritiesHDFC Securities suggests adding Alkem Laboratories shares, targeting Rs 5,700. Alkem, a large pharmaceutical company, reported its financia...
17 Apr, 2025, 08.51 AM IST
Add Alkem Laboratories, target price Rs 6,180: HDFC SecuritiesHDFC Securities recommends buying shares of Alkem Laboratories. They set a target price of Rs 6,180. The current market price is Rs 5,535. ...
15 Nov, 2024, 09.11 AM IST
Alkem Labs diversifies into medical devices bizAlkem Laboratories has become the first Indian drugmaker to diversify into medical devices after partnering with US-based Exactech to manuf...
23 Aug, 2024, 12.26 AM IST
Add Alkem Laboratories, target price Rs 5520: HDFC SecuritiesAlkem Laboratories Ltd., incorporated in the year 1973, is a Large Cap company (having a market cap of Rs 60260.76 Crore) operating in Phar...
13 Mar, 2024, 10.02 AM IST
Alkem Labs plunges more than 13%, sees biggest single-day fall in over 3 years on tax evasion allegationIn September last year, the tax department conducted surveys on the offices and premises of the company after receiving intelligence regard...
26 Feb, 2024, 04.01 PM IST
Buy Alkem Laboratories, target Rs 2,340: HDFC SecuritiesBuy Alkem Laboratories at a price target of Rs 2,340.
12 Feb, 2019, 12.47 PM IST
- Accumulate Alkem Laboratories, target Rs 2,441: Angel Broking
Accumulate Alkem Laboratories Ltd. at a price target of Rs 2441.0 .
12 Mar, 2018, 07.52 AM IST
Alkem's Mandva plant gets establishment nod from USFDAAlkem Labs Ltd today said one of its manufacturing plants in Gujarat has obtained the Establishment Inspection Report (EIR) "approval" from...
07 Mar, 2016, 12.59 PM IST